Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 2;17(12):5139-5141.
doi: 10.1080/21645515.2021.1922265.

Increasing COVID-19 vaccine acceptance among the general population while maintaining autonomy

Dorcas Serwaa  1 , Emmanuel Lamptey  1 , Ephraim Kumi Senkyire  2
Affiliations

Increasing COVID-19 vaccine acceptance among the general population while maintaining autonomy

Dorcas Serwaa et al. Hum Vaccin Immunother. .

Abstract

The accelerated dissemination of coronavirus disease, its effects on the general public and healthcare system have been unparalleled. COVID-19 vaccination is critical for reducing the alarming incidence of the infection, promoting herd immunity, preventing associated mortality and morbidity, and maintaining public health and safety. Through the development of COVID-19 vaccines, many people are keen to protect themselves against the virus; however, the willingness for vaccination especially in Africa, is far below what is required to stop the ongoing COVID-19 pandemic. As a result, there is an immediate need to implement plans aimed at increasing population vaccine willingness. The slippery slope is whether sanctions, bans and restriction should be imposed on hesitant persons, since transmission of the epidemic can be prevented through stringent enforcement of the control barriers, while eradicating the disease would necessitate vaccination. This commentary provides recommendations about how to increase population vaccine acceptance while maintaining autonomy.

Keywords: Autonomy; COVID-19; vaccination; vaccine acceptance; vaccine hesitancy.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Lango MN. How did we get here? Short history of COVID‐19 and other coronavirus‐related epidemics. Head Neck. 2020;42(7):1535–38. doi:10.1002/hed.26275. - DOI - PMC - PubMed
    1. Bai Y, Yao L, Wei T, Tian F, Jin D-Y, Chen L, Wang M.. Presumed asymptomatic carrier transmission of COVID-19. Jama. 2020;323(14):1406–07. doi:10.1001/jama.2020.2565. - DOI - PMC - PubMed
    1. Heesterbeek H, Anderson RM, Andreasen V, Bansal S, De Angelis D, Dye C, Eames KT, Edmunds WJ, Frost SD, Funk S. et al. Modeling infectious disease dynamics in the complex landscape of global health. Science (80-). 2015;347:6227. doi:10.1126/science.aaa4339. - DOI - PMC - PubMed
    1. Li W, Zhang B, Lu J, Liu S, Chang Z, Peng C, Liu X, Zhang P, Ling Y, Tao K, et al. Characteristics of household transmission of COVID-19. Clin Infect Dis. 2020;71(8):1943–46. doi:10.1093/cid/ciaa450. - DOI - PMC - PubMed
    1. Brooks HE, McLendon LA, Daniel CL. The impact of COVID-19 on pediatric vaccination rates in Alabama. Prev Med Reports. 2021;22:101320. doi:10.1016/j.pmedr.2021.101320. - DOI - PMC - PubMed

Substances